EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Rapid Response to Trametinib Combined With Chemotherapy for Infant BRAF‐Fused Chiasmatic Glioma

Helen Toledano, Alexander Yelak, Walid Kaadan, Shlomo Caduri, Rivka Friedland, Orli Michaeli, Gad Dotan, Osnat Konen

Pediatric Blood & Cancer · 2026-06 · 73 (6)

DOI: 10.1002/1545-5017.70258 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Pediatric Blood & Cancer, online erschienen am 17.03.2026. Verfasst von Helen Toledano und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Hematology-Oncology, Schneider Children's Medical Center of Israel, Petah Tikva, Israel. Hauptthemen laut MEDLINE: Antineoplastic Combined Chemotherapy Protocols, Glioma, Oncogene Proteins, Fusion, Optic Chiasm. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Infants, less than 1 year, with chiasmatic gliomas (ICG) present a major therapeutic challenge due to large tumor size, decreased vision, rapid progression, and poor response to vincristine/carboplatin chemotherapy. The majority have a BRAF fusion, which may respond to downstream MEK inhibitors but response time is slow. There are no safety or efficacy data for MEK inhibitors in infants or in combination with chemotherapy. We report two infants with BRAF‐fused ICG presenting at age 5 months with nystagmus and diencephalic syndrome. Significant tumor progression occurred after only 6 weeks on chemotherapy and showed dramatic response to the addition of trametinib.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic Combined Chemotherapy ProtocolsGliomaOncogene Proteins, FusionOptic ChiasmProto-Oncogene Proteins B-rafFemaleHumansInfantCarboplatinPyridonesPyrimidinonesVincristine

Stichwörter der Autor:innen

chemotherapychiasmatic gliomainfanttrametinib

Substanzen

BRAF protein, humanCarboplatinOncogene Proteins, FusionProto-Oncogene Proteins B-rafPyridonesPyrimidinonestrametinibVincristine

Autor:innen und Institutionen

  • Department of Pediatric Hematology-Oncology, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.
  • Gray Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Department of Radiology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.
  • Department of Radiology, Rabin Medical Center, Petach Tikva, Israel.
  • Pediatric Dermatology Unit, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.
  • Department of Ophthalmology, Ophthalmology Unit, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.

Zitieren

APA

Toledano, H., Yelak, A., Kaadan, W., Caduri, S., Friedland, R., Michaeli, O., Dotan, G., & Konen, O. (2026). Rapid Response to Trametinib Combined With Chemotherapy for Infant BRAF‐Fused Chiasmatic Glioma. Pediatric Blood & Cancer, 73(6). https://doi.org/10.1002/1545-5017.70258

Vancouver

Toledano H, Yelak A, Kaadan W, Caduri S, Friedland R, Michaeli O, et al. Rapid Response to Trametinib Combined With Chemotherapy for Infant BRAF‐Fused Chiasmatic Glioma. Pediatric Blood & Cancer. 2026;73(6). doi:10.1002/1545-5017.70258

BibTeX
@article{Toledano2026,
  author = {Toledano, Helen and Yelak, Alexander and Kaadan, Walid and Caduri, Shlomo and Friedland, Rivka and Michaeli, Orli and Dotan, Gad and Konen, Osnat},
  title = {Rapid Response to Trametinib Combined With Chemotherapy for Infant BRAF‐Fused Chiasmatic Glioma},
  journal = {Pediatric Blood & Cancer},
  year = {2026},
  volume = {73},
  number = {6},
  doi = {10.1002/1545-5017.70258}
}
Kostenlos starten →